Further studies towards identifying the signaling intermediates of, and binding partners for, ADIPOR1 could additionally provide an avenue for therapeutic intervention by revealing novel targets for drug design for the treatment of basal-like breast cancers. Here, ADIPOR1 is linked to breast carcinoma.